Related Experiment Video

Updated: May 17, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

Targeting SPARC by lentivirus-mediated RNA interference inhibits cervical cancer cell growth and metastasis

Jie Chen1, Dehuan Shi, Xiaoyan Liu

  • 1Department of Maternal and Child Health Care, School of Public Health, Shandong University, Jinan 250012, China.

BMC Cancer
|October 12, 2012
PubMed
Abstract

Insights

Secreted protein acidic and rich in cysteine (SPARC) promotes cervical cancer growth and metastasis. Reducing SPARC levels suppressed tumor cell proliferation, induced apoptosis, and inhibited invasion, offering a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Secreted protein acidic and rich in cysteine (SPARC) is a matricellular glycoprotein involved in cancer progression.
  • The role of SPARC in cervical cancer cell growth and metastasis remains largely unexplored.

Purpose of the Study:

  • To investigate the function of SPARC in cervical cancer cell proliferation, apoptosis, invasion, and metastasis.
  • To elucidate the underlying molecular mechanisms of SPARC action in cervical cancer.

Main Methods:

  • Established highly and lowly invasive cervical cancer cell subclones (HeLa, SiHa).
  • Utilized quantitative real-time PCR, Western Blot, and immunocytochemistry to assess SPARC expression.
  • Employed lentivirus-mediated SPARC shRNA for gene knockdown and functional assays.

Main Results:

  • SPARC was significantly overexpressed in highly invasive cervical cancer subclones.
  • SPARC knockdown suppressed cell proliferation via p53/p21 pathway, induced apoptosis (altered Bcl-2/Bax ratio), and inhibited invasion/metastasis (modulated MMP2, MMP9, E-cadherin).

Conclusions:

  • SPARC expression correlates with the invasive phenotype of cervical cancer cells.
  • SPARC knockdown effectively suppresses cervical cancer cell growth, apoptosis, invasion, and metastasis.
  • SPARC acts as a promoter of cervical cancer progression, representing a potential therapeutic target.

More Related Videos

DNA Vector-based RNA Interference to Study Gene Function in Cancer13:10

DNA Vector-based RNA Interference to Study Gene Function in Cancer

Published on: June 4, 2012

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...